Stocks

The shares of Cassava Sciences demonstrated extreme price swings over the past week, culminating in a Friday decline of 3.55%...

Regeneron Pharmaceuticals has achieved a significant regulatory milestone, receiving FDA approval to administer its cholesterol-lowering drug Evkeeza to children as...

Workday is making a massive strategic bet on artificial intelligence, but this focus has attracted significant legal and regulatory challenges...

Biogen, the biotechnology giant, finds itself navigating contrasting fortunes as its key therapeutic programs advance on divergent paths. While the...

America's railway infrastructure could soon undergo its most significant consolidation in modern history. Union Pacific is currently engaged in advanced...

Trading at a staggering 60% discount to its stated net asset value, Prospect Capital presents investors with a compelling yet...

Financial analysts are raising concerns about Warner Bros. Discovery's (A) valuation, even as the media conglomerate celebrates streaming successes and...

The travel platform Airbnb finds itself navigating complex terrain as it pursues ambitious expansion while confronting growing regulatory pressures across...

Visa is making strategic moves to strengthen its position in the digital payments landscape through an unexpected partnership with fintech...

Danaher Corporation finds itself navigating turbulent legal waters as securities litigation gains momentum against the life sciences conglomerate. A federal...